Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
ELV Quote, Financials, Valuation and Earnings
Last price:
$302.32
Seasonality move
:
-0.81%
Day range:
$296.39 - $334.00
52-week range:
$296.39 - $567.26
Dividend yield:
2.21%
P/E ratio:
11.80x
P/S ratio:
0.38x
P/B ratio:
1.61x
Volume:
7.4M
Avg. volume:
2M
1-year change:
-41.94%
Market cap:
$68.3B
Revenue:
$176.8B
EPS (TTM):
$25.63
Earnings Data
Next earnings date for ELV
Jul 17
2025
Most recent earnings per share
$9.61
Missed by $1.87
(Apr 22/2025)
Consensus Estimate
$11.48
(Apr 22/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ELV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $48.7B | -- | -- | $8.48 | -- |
| 07/17/2025 | Q2 | $48.2B | -- | -- | $8.92 | -- |
| 04/22/2025 | Q1 | $46.2B | $48.9B | $9.61 | $11.48 | -$1.87 |
| 01/23/2025 | Q4 | $44.7B | $45.4B | $1.81 | $3.85 | -$2.04 |
| 10/17/2024 | Q3 | $43.1B | $45.1B | $4.36 | $9.65 | -$5.29 |
| 07/17/2024 | Q2 | $42.9B | $43.6B | $9.85 | $10.01 | -$0.16 |
| 04/18/2024 | Q1 | $42.4B | $42.6B | $9.59 | $10.53 | -$0.94 |
| 01/24/2024 | Q4 | $42.2B | $42.6B | $3.63 | $5.59 | -$1.96 |
| 10/18/2023 | Q3 | $42.7B | $42.8B | $5.45 | $8.46 | -$3.01 |
| 07/19/2023 | Q2 | $41.5B | $43.7B | $7.79 | $8.77 | -$0.98 |
| 04/19/2023 | Q1 | -- | $42.2B | $8.30 | -- | -- |
| 01/25/2023 | Q4 | -- | $39.9B | $3.93 | -- | -- |
| 10/19/2022 | Q3 | -- | $39.9B | $6.62 | -- | -- |
| 07/20/2022 | Q2 | -- | $38.6B | $6.73 | -- | -- |
| 04/20/2022 | Q1 | -- | $38.1B | $7.32 | -- | -- |
| 12/31/2021 | Q4 | -- | $36.6B | $4.63 | -- | -- |
| 09/30/2021 | Q3 | -- | $35.8B | $6.13 | -- | -- |
| 06/30/2021 | Q2 | -- | $33.9B | $7.25 | -- | -- |
| 03/31/2021 | Q1 | -- | $32.4B | $6.71 | -- | -- |
| 12/31/2020 | Q4 | -- | $31.8B | $2.19 | -- | -- |
| 09/30/2020 | Q3 | -- | $31.2B | $0.87 | -- | -- |
| 06/30/2020 | Q2 | -- | $29.3B | $8.91 | -- | -- |
| 03/31/2020 | Q1 | -- | $29.6B | $5.94 | -- | -- |
| 12/31/2019 | Q4 | -- | $27.4B | $3.62 | -- | -- |
| 09/30/2019 | Q3 | -- | $26.7B | $4.55 | -- | -- |
| 06/30/2019 | Q2 | -- | $25.5B | $4.36 | -- | -- |
| 03/31/2019 | Q1 | -- | $24.7B | $5.91 | -- | -- |
| 12/31/2018 | Q4 | -- | $23.4B | $1.61 | -- | -- |
| 09/30/2018 | Q3 | -- | $23.3B | $3.62 | -- | -- |
| 06/30/2018 | Q2 | -- | $22.9B | $3.98 | -- | -- |
| 03/31/2018 | Q1 | -- | $22.5B | $4.99 | -- | -- |
| 12/31/2017 | Q4 | -- | $22.7B | $4.67 | -- | -- |
| 09/30/2017 | Q3 | -- | $22.4B | $2.80 | -- | -- |
| 06/30/2017 | Q2 | -- | $22.4B | $3.16 | -- | -- |
| 03/31/2017 | Q1 | -- | $22.5B | $3.73 | -- | -- |
| 12/31/2016 | Q4 | -- | $21.7B | $1.37 | -- | -- |
| 09/30/2016 | Q3 | -- | $21.4B | $2.30 | -- | -- |
| 06/30/2016 | Q2 | -- | $21.5B | $2.91 | -- | -- |
| 03/31/2016 | Q1 | -- | $20.3B | $2.63 | -- | -- |
| 12/31/2015 | Q4 | -- | $20.2B | $0.68 | -- | -- |
| 09/30/2015 | Q3 | -- | $19.9B | $2.43 | -- | -- |
Elevance Health Earnings Questions
-
How Much did Elevance Health Generate in Revenue Last Quarter?
Elevance Health reported $48.9B worth of top line sales in its most recent quarter.
-
Did Elevance Health Beat Earnings Last Quarter?
Elevance Health announced earnings per share of $9.61 which represents a miss of analyst forecast a $11.48 per share.
-
Is Elevance Health Profitable?
Elevance Health reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Elevance Health EPS Next Year?
Elevance Health's earnings are forecast to grow from $25.68 per share to $32.96 per share next year representing an increase of 31.51%.
-
When is Elevance Health's Earnings Date?
Currently, Elevance Health has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on October 16, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
